Xu, Yinyan
https://orcid.org/0000-0001-7960-8278
Mayo Clinic
Hematology/Oncology Celgene Corporation Shanghai China
Citations 1
ROBUST: PHASE III RANDOMIZED STUDY OF LENALIDOMIDE/R‐CHOP VS PLACEBO/R‐CHOP IN UNTREATED ABC‐TYPE DIFFUSE LARGE B‐CELL LYMPHOMA AND FEASIBILITY OF CELL OF ORIGIN SUBTYPING
Gascoyne, Randy D. , Russo, Jacqueline, Amoroso, Barbara, Hudak, Krista, Ogunkanmi, A., Xu, Yinyan , Ruiz, Wanda, Singh, Shailesh , Nowakowski, Grzegorz S. , Chiappella, Annalisa , Witzig, Thomas E. , Vitolo, Umberto , Singh, S.
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 419-419
